Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-01

Clinical Trial Update: ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia [Phase 4]

View source ↗

Summary

This entry provides a Phase 4 clinical trial update evaluating ATG-based therapy with cyclophosphamide and cord blood transfusion for severe aplastic anemia. Sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATG (anti-thymocyte globulin)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Jinan Military General Hospital | Conditions: Aplastic Anemia | Phase 4 | Status: UNKNOWN